Silver Book Fact

AFib practice guidelines reduce direct health care costs

The use of practice guidelines in atrial fibrillation (AF) patients significantly decreased hospitalization and resource utilization—with an average decrease in 30-day total direct health care costs of around $1,400 per patient.

Zimetbaum P, Reynolds M, Ho K, Gaziano T, et al. Impact of a Practice Guideline for Patients with Atrial Fibrillation on Medical Resource Utilization and Costs. Am J Cardiol. 2003; 92(6): 677-81. http://www.ajconline.org/article/S0002-9149(03)00821-X/abstract

Reference

Title
Impact of a Practice Guideline for Patients with Atrial Fibrillation on Medical Resource Utilization and Costs
Publication
Am J Cardiol
Publication Date
2003
Authors
Zimetbaum P, Reynolds M, Ho K, Gaziano T, et al
Volume & Issue
Volume 92, Issue 6
Pages
677-81
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Effect of optimal anticoagulation
    If 50% of atrial fibrillation patients who currently receive warfarin in routine medical care were optimally anticoagulated, 9,852 emboli would be prevented and $1.3 billion would be saved each year.  
  • Adjusted-dose warfarin reduced stroke risk in AFib patients
    Meta-analysis of randomized trials found that adjusted-dose warfarin reduced stroke risk in atrial fibrillation patients by 60%. Antiplatelet agents reduced risk by 20%.  
  • Identifying individuals at high risk for developing AFib
    Using simple bedside measures, identification of individuals at risk for developing atrial fibrillation is feasible. Selecting high-risk individuals for inclusion in atrial fibrillation prevention trials may also enhance prevention strategies.  
  • Stroke risk reduction from thrombin inhibitor in AFib patients
    A recently approved direct thrombin inhibitor was found to reduce the risk of stroke/peripheral embolic events in atrial fibrillation patients by 34%, and the risk of hemorrhagic stroke by 74%—compared…  
  • t-PA cost savings
    The total annual benefit to society from t-PA use in the United States is around $363 million—$60 million in direct cost savings to society plus an additional 7,510 QALYs. This means…